| Lastest Insider Transactions Of Akebia Therapeutics, Inc. ( AKBA ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | 2026-08-06 | Option Exercise | 350,000 | 0.63 | 220,500 | 2026-08-10 16:08:41 |
| AKBA | Akebia Therapeutics, Inc. | Ostrowski Erik | SVP, CFO, CBO & Treasurer | 2026-06-29 | Sell | 56,019 | 1.11 | 62,181 | 2026-07-01 16:34:14 |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | 2026-03-04 | Buy | 69,270 | 1.25 | 86,588 | 2026-03-05 18:55:46 |
| AKBA | Akebia Therapeutics, Inc. | Malabre Richard C | SVP, Chief Accounting Officer | 2026-02-02 | Sell | 49,524 | 1.39 | 68,838 | 2026-02-04 16:15:29 |
| AKBA | Akebia Therapeutics, Inc. | Grund Nicholas | Chief Commercial Officer | 2026-02-02 | Sell | 84,829 | 1.39 | 117,912 | 2026-02-04 16:13:46 |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | 2026-02-02 | Sell | 67,658 | 1.39 | 94,045 | 2026-02-04 16:13:17 |
| AKBA | Akebia Therapeutics, Inc. | Rucci Carolyn M. | SVP, Chief Legal Officer | 2026-02-02 | Sell | 69,772 | 1.39 | 96,983 | 2026-02-04 16:12:00 |
| AKBA | Akebia Therapeutics, Inc. | Ostrowski Erik | SVP, CFO, CBO & Treasurer | 2026-02-02 | Sell | 34,951 | 1.39 | 48,582 | 2026-02-04 16:11:02 |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | 2026-02-02 | Sell | 341,305 | 1.39 | 474,414 | 2026-02-04 16:10:28 |
| AKBA | Akebia Therapeutics, Inc. | Ostrowski Erik | SVP, CFO, CBO & Treasurer | 2025-06-30 | Sell | 41,314 | 3.67 | 151,622 | 2025-07-01 17:01:37 |
| AKBA | Akebia Therapeutics, Inc. | Ostrowski Erik | SVP, CFO, CBO & Treasurer | 2025-06-30 | Sell | 41,314 | 3.67 | 151,622 | 2025-07-01 17:01:37 |
| AKBA | Akebia Therapeutics, Inc. | Malabre Richard C | SVP, Chief Accounting Officer | 2025-06-09 | Sell | 15,000 | 4.01 | 60,150 | 2025-06-11 17:13:30 |
| AKBA | Akebia Therapeutics, Inc. | Malabre Richard C | SVP, Chief Accounting Officer | 2025-06-09 | Option Exercise | 15,000 | 1.68 | 25,200 | 2025-06-11 17:13:30 |
| AKBA | Akebia Therapeutics, Inc. | Malabre Richard C | SVP, Chief Accounting Officer | 2025-06-04 | Sell | 13,334 | 3.53 | 47,069 | 2025-06-05 16:35:02 |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | 2025-03-03 | Sell | 46,409 | 1.83 | 84,928 | 2025-03-04 17:05:06 |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | 2025-03-03 | Sell | 7,144 | 1.83 | 13,074 | 2025-03-04 17:04:33 |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | 2025-01-31 | Sell | 144,250 | 2.10 | 302,925 | 2025-02-04 17:54:18 |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | 2025-01-31 | Sell | 50,506 | 2.10 | 106,063 | 2025-02-04 17:53:09 |
| AKBA | Akebia Therapeutics, Inc. | Malabre Richard C | SVP, Chief Accounting Officer | 2025-01-31 | Sell | 30,202 | 2.10 | 63,424 | 2025-02-04 17:52:20 |
| AKBA | Akebia Therapeutics, Inc. | Grund Nicholas | Chief Commercial Officer | 2025-01-31 | Sell | 55,621 | 2.10 | 116,804 | 2025-02-04 17:51:42 |
| AKBA | Akebia Therapeutics, Inc. | FRIESON RON | Directior | 2025-01-17 | Option Exercise | 20,100 | 0.45 | 9,045 | 2025-01-22 16:06:17 |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, Chief Legal Officer | 2024-05-13 | Sell | 12,016 | 1.26 | 15,140 | 2024-05-14 16:05:25 |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | 2024-05-13 | Sell | 34,840 | 1.26 | 43,898 | 2024-05-14 16:04:58 |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | 2023-08-25 | Sell | 27,000 | 1.15 | 31,050 | 2024-05-09 17:27:19 |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | 2024-02-29 | Sell | 8,661 | 1.58 | 13,684 | 2024-03-01 17:49:20 |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, Chief Legal Officer | 2024-02-29 | Sell | 5,974 | 1.58 | 9,439 | 2024-03-01 17:48:25 |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | 2024-02-29 | Sell | 46,570 | 1.58 | 73,581 | 2024-03-01 17:47:34 |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | 2024-02-29 | Sell | 7,169 | 1.58 | 11,327 | 2024-03-01 17:46:51 |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, Chief Legal Officer | 2024-02-27 | Sell | 7,411 | 1.52 | 11,265 | 2024-02-29 18:03:48 |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | 2024-02-27 | Sell | 10,744 | 1.52 | 16,331 | 2024-02-29 18:02:40 |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | 2024-02-27 | Sell | 8,367 | 1.52 | 12,718 | 2024-02-29 18:01:46 |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | 2024-02-27 | Sell | 37,733 | 1.52 | 57,354 | 2024-02-29 18:00:49 |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | 2024-01-31 | Sell | 46,489 | 1.68 | 78,102 | 2024-02-02 16:10:30 |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | 2024-01-31 | Sell | 24,311 | 1.68 | 40,842 | 2024-02-02 16:10:01 |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, Chief Legal Officer | 2023-05-24 | Sell | 63,186 | 1.22 | 77,270 | 2023-05-25 21:01:34 |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | 2023-05-24 | Sell | 95,478 | 1.22 | 116,760 | 2023-05-25 21:01:04 |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | 2023-05-16 | Sell | 63,567 | 1.07 | 67,890 | 2023-05-18 18:20:45 |
| AKBA | Akebia Therapeutics, Inc. | Spellman David A | SVP, CFO and Treasurer | 2023-05-16 | Sell | 63,567 | 1.07 | 67,890 | 2023-05-18 18:19:49 |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | 2023-03-01 | Sell | 91,868 | 0.88 | 80,614 | 2023-03-03 08:01:34 |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, Chief Legal Officer | 2023-03-01 | Sell | 13,034 | 0.88 | 11,437 | 2023-03-03 08:01:24 |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | 2023-03-01 | Sell | 14,123 | 0.88 | 12,393 | 2023-03-03 08:01:13 |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | 2023-03-01 | Sell | 20,412 | 0.88 | 17,912 | 2023-03-03 08:01:05 |
| AKBA | Akebia Therapeutics, Inc. | Spellman David A | SVP, CFO and Treasurer | 2023-03-01 | Sell | 7,210 | 0.88 | 6,327 | 2023-03-03 08:00:54 |
| AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO and President | 2023-02-27 | Sell | 38,632 | 0.81 | 31,416 | 2023-03-01 16:07:05 |
| AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | 2023-02-27 | Sell | 7,539 | 0.81 | 6,131 | 2023-03-01 16:06:40 |
| AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, Chief Operating Officer | 2023-02-27 | Sell | 10,090 | 0.81 | 8,205 | 2023-03-01 16:06:17 |
| AKBA | Akebia Therapeutics, Inc. | Spellman David A | SVP, CFO and Treasurer | 2023-02-27 | Sell | 7,539 | 0.81 | 6,131 | 2023-03-01 16:05:50 |
| AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, Chief Legal Officer | 2023-02-27 | Sell | 6,677 | 0.81 | 5,430 | 2023-03-01 16:05:39 |
